A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse
Condition(s):Non-small Cell Lung Cancer Stage IIIALast Updated:September 21, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Non-small Cell Lung Cancer Stage IIIALast Updated:September 21, 2023Recruiting
Condition(s):Neoplasm of Lung; Decision Support Techniques; Mass ScreeningLast Updated:December 10, 2020Completed
Condition(s):Oncology & Epidemiology & Lung CancerLast Updated:March 16, 2022Completed
Condition(s):Non Small Cell Lung CancerLast Updated:April 7, 2023Not yet recruiting
Condition(s):Head and Neck CancerLast Updated:January 22, 2024Not yet recruiting
Condition(s):SCLC, Extensive StageLast Updated:April 12, 2022Recruiting
Condition(s):Lung CancerLast Updated:September 28, 2023Recruiting
Condition(s):Lung Cancer; COPDLast Updated:March 4, 2021Completed
Condition(s):Lung CancerLast Updated:October 23, 2020Completed
Condition(s):Lung CancerLast Updated:December 30, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.